These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17003917)

  • 1. Transcription-based COX-2 inhibition: a therapeutic strategy.
    Wu KK
    Thromb Haemost; 2006 Oct; 96(4):417-22. PubMed ID: 17003917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate.
    Cieslik KA; Zhu Y; Shtivelband M; Wu KK
    J Biol Chem; 2005 May; 280(18):18411-7. PubMed ID: 15738002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Control of COX-2 via C/EBPbeta.
    Wu KK; Liou JY; Cieslik K
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):679-85. PubMed ID: 15681294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
    Wu KK
    Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes.
    Sun H; Xu B; Inoue H; Chen QM
    Cell Signal; 2008 Nov; 20(11):1952-9. PubMed ID: 18657608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
    Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
    J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding.
    Deng WG; Montero AJ; Wu KK
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1752-9. PubMed ID: 17556653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the COX-2 expression by nitric oxide in colon cancer cell lines.
    Liu Q; Inoue H; Mahendran R
    Oncol Rep; 2008 Jan; 19(1):269-74. PubMed ID: 18097606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An upstream CRE-E-box element is essential for gastrin-dependent activation of the cyclooxygenase-2 gene in human colon cancer cells.
    Ansorge N; Jüttner S; Cramer T; Schmidt WE; Höcker M; Schmitz F
    Regul Pept; 2007 Dec; 144(1-3):25-33. PubMed ID: 17604853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
    Luna M; Wong S; Ferrario A; Gomer CJ
    Photochem Photobiol; 2008; 84(2):509-14. PubMed ID: 18282182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
    Wang W; Bergh A; Damber JE
    Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.
    Klampfer L; Huang J; Kaler P; Sasazuki T; Shirasawa S; Augenlicht L
    Oncogene; 2007 Mar; 26(14):2071-81. PubMed ID: 17016440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells.
    Pham H; Chong B; Vincenti R; Slice LW
    J Cell Physiol; 2008 Jan; 214(1):96-109. PubMed ID: 17559081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators.
    Wu KK
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):89-93. PubMed ID: 15626591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
    Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
    Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cyclooxygenase-2 transcriptional control in proliferating versus quiescent fibroblasts.
    Wu KK
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):175-81. PubMed ID: 17481552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific proteolysis of cyclooxygenase-2: a putative step in inflammatory prostaglandin E(2) biosynthesis.
    Mancini A; Jovanovic DV; He QW; Di Battista JA
    J Cell Biochem; 2007 May; 101(2):425-41. PubMed ID: 17177291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.
    Chan MW; Wong CY; Cheng AS; Chan VY; Chan KK; To KF; Chan FK; Sung JJ; Leung WK
    Oncol Rep; 2007 Dec; 18(6):1557-62. PubMed ID: 17982644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.